Salicylihalamides A and B, Novel Cytotoxic Macrolides from the Marine Sponge Haliclona sp.

J Org Chem

Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment, Diagnosis, and Centers, National Cancer Institute-FCRDC, Building 1052, Room 121, Frederick, Maryland 21702-1201.

Published: November 1997

Two novel, highly potent, cytotoxic macrolides, salicylihalamides A (1) and B (2), were isolated from the sponge Haliclona sp. This new macrolide class incorporates salicylic acid, a 12-membered lactone ring, and an enamide side chain. COMPARE pattern-recognition analyses of the NCI 60-cell mean graph screening profiles of 1 did not reveal any significant correlations to the profiles of known antitumor compounds in the NCI's "standard agent database", thus supporting the conclusion that the salicylihalamides represent a potentially important new class for antitumor lead optimization and in vivo investigations.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jo971556gDOI Listing

Publication Analysis

Top Keywords

cytotoxic macrolides
8
sponge haliclona
8
salicylihalamides novel
4
novel cytotoxic
4
macrolides marine
4
marine sponge
4
haliclona novel
4
novel highly
4
highly potent
4
potent cytotoxic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!